Division of Urology, Department of Surgery, The University of Texas Medical School at Houston, Houston, Texas, USA.
J Endourol. 2010 Jun;24(6):1005-12. doi: 10.1089/end.2009.0532.
Laparoscopy-assisted radical nephrectomy and vena caval thrombectomy (LARN-VCT) is reported to be an alternative to open surgery for renal-cell carcinoma (RCC). We describe our experience and review the current literature evaluating the feasibility and safety of LARN-VCT.
We retrospectively reviewed the medical records of all patients who underwent laparoscopic radical nephrectomy for RCC at our institution between June 2004 and May 2009, and selected those who underwent LARN-VCT. We analyzed patients' clinical, radiographic, intraoperative, pathologic, and postoperative parameters. For the literature review, we performed a MEDLINE search to identify publications that focused on laparoscopic radical nephrectomy with VCT.
LARN-VCT was completed in six of seven patients; elective conversion in one patient to open surgery occurred because of disease progression. Five of the six patients with RCC had no evidence of disease recurrence at a median follow-up of 16 months. The literature review revealed case reports and small series demonstrating the technical feasibility and safety of LARN-VCT in selected patients.
LARN-VCT is a technically feasible approach in carefully selected patients with right-sided level II to III tumor thrombus. Optimal patient selection, extensive laparoscopic experience, and multidisciplinary support are critical elements for the safe application of this approach. Fluid and volume resuscitation must be thoughtfully considered given the transition from laparoscopy to open cross clamping of the vena cava. The worldwide literature on LARN-VCT is still limited and additional data are needed.
腹腔镜辅助根治性肾切除术和腔静脉取栓术(LARN-VCT)被报道为肾细胞癌(RCC)的开放手术的替代方法。我们描述了我们的经验,并回顾了目前评估 LARN-VCT 的可行性和安全性的文献。
我们回顾性地分析了 2004 年 6 月至 2009 年 5 月期间在我们机构接受腹腔镜根治性肾切除术治疗 RCC 的所有患者的病历,并选择了接受 LARN-VCT 的患者。我们分析了患者的临床、影像学、术中、病理和术后参数。为了文献回顾,我们在 MEDLINE 上进行了搜索,以确定重点关注腹腔镜根治性肾切除术伴 VCT 的出版物。
LARN-VCT 完成于 7 例患者中的 6 例;1 例患者因疾病进展而选择择期转为开放性手术。在中位随访 16 个月时,6 例 RCC 患者中有 5 例无疾病复发的证据。文献回顾显示,在一些选定的患者中,LARN-VCT 的技术可行性和安全性已得到病例报告和小系列研究的证实。
在仔细选择的右侧 II 级至 III 级肿瘤血栓患者中,LARN-VCT 是一种可行的技术方法。最佳的患者选择、广泛的腹腔镜经验和多学科支持是安全应用这种方法的关键因素。由于从腹腔镜转为开放腔静脉交叉夹闭,必须仔细考虑液体和容量复苏。关于 LARN-VCT 的全球文献仍然有限,需要更多的数据。